Quantcast

Garden State Times

Saturday, November 23, 2024

FDA conducted third highest number of inspections on device companies in New Jersey during Q2 2023

Webp qjor7q6aba3j2gn1lh89sh3yxtfn

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

In the second quarter of 2023, seven device companies received seven FDA inspections in New Jersey, according to the U.S. Food and Drug Administration (FDA).

This was the third highest number of inspections per type of company made by the FDA in New Jersey, equalling 8.3% of all inspections in the second quarter of 2023.

Of all the New Jersey companies involved in the device sector, Parker Laboratories, Inc. received the most citations from the FDA in the second quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in New Jersey During Q2 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring4----
Blood and Blood Products2----
Colors and Cosmetics Technology1----
Compliance: Devices15--
Drug Quality Assurance36--
Food Composition, Standards, Labeling and Econ131--
Foodborne Biological Hazards3219--
Human Cellular, Tissue, and Gene Therapies11--
Monitoring of Marketed Animal Drugs, Feed, and Devices31--
Postmarket Assurance: Devices3----

MORE NEWS